Overview

Lavo Life Sciences' AI-accelerated tool revolutionizes crystal structure prediction for small molecule drugs. This cutting-edge solution leverages the power of AI and computational chemistry to significantly streamline and de-risk the drug development process. By predicting crystal structures early, it helps optimize solid-state formulations and avoid costly late-stage setbacks.

Features

• AI-powered prediction: Accurately predicts the crystal structure of drug molecules in their molecular form.
• Polymorph discovery: Identifies novel polymorphs with potentially improved properties, such as enhanced stability or manufacturability.
• Faster turnaround time: Significantly reduces the time required for crystal form identification.
• Optimized formulations: Helps optimize drug formulations for enhanced stability and manufacturability.
• Risk mitigation: Minimizes the risk of unexpected crystal forms impacting development timelines and costs.

Benefits

• Accelerated drug development: Speeds up the overall drug development process through early prediction and optimization.
• Reduced costs: Avoids costly late-stage changes and formulation issues.
• Improved drug product quality: Leads to more stable and manufacturable drug formulations.
• Enhanced innovation: Facilitates the discovery of novel polymorphs with superior properties.
• De-risked pipelines: Helps minimize uncertainties and surprises during drug development.

Use Cases

• Pharmaceutical companies: Streamlines crystal structure prediction and formulation development for new drug candidates.
• Contract research organizations (CROs): Provides a powerful tool for accelerating drug development projects for clients.

Lavo Life Sciences' AI tool empowers drug development teams with faster, more efficient, and less risky pathways to bringing new medicines to market.